Translate this page into:
Selected Summary
PMID: 27586215
Anti-emetic trials in oncology: What should be done next?
Sameer Rastogi1 , Sameer Bakhshi1 , A Aggarwal2
1 Department of Medical Oncology, Dr B.R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
2 Department of Radiation Oncology, Fortis Noida, Uttar Pradesh, India
Corresponding Author:
Sameer Rastogi
Department of Medical Oncology, Dr B.R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi
India
samdoc_mamc@yahoo.com
2 Department of Radiation Oncology, Fortis Noida, Uttar Pradesh, India
Corresponding Author:
Sameer Rastogi
Department of Medical Oncology, Dr B.R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi
India
samdoc_mamc@yahoo.com
| How to cite this article: Rastogi S, Bakhshi S, Aggarwal A. Anti-emetic trials in oncology: What should be done next?. Natl Med J India 2016;29:90-91 |
Copyright: (C)2016 The National Medical Journal of India
Fulltext Views
928
PDF downloads
339
